Breast Cancer Meeting Highlights - Page 5 - HER2 Support Group Forums

		HER2 Support Group Forums
Breast Cancer Meeting Highlights

Breast Cancer Meeting Highlights News fro recent ASCO and San Antonio Meetings

Page 5 of 14

« First

Last »

Threads in Forum : Breast Cancer Meeting Highlights

Forum Tools

Search this Forum

Rating Thread / Thread Starter	Last Post	Replies	Views
San Antonio Abstracts on line Early Hopeful	12-02-2008 09:42 AM by Hopeful	0	1,270
Reduction of chemotherapy side effects with a calcium phosphate nanoparticle delivery Hopeful	12-04-2008 07:57 AM by Hopeful	0	1,471
Clinical outcomes of patients with T1N0 breast cancers: how important are biological Hopeful	12-04-2008 07:54 AM by Hopeful	0	1,245
Estimating recurrences prevented from using trastuzumab in adjuvant bc in the USA Hopeful	12-04-2008 07:55 AM by Hopeful	0	1,321
MG28, a novel fatty acid synthase inhibitor, overcomes resistance to anti-HER therapy Hopeful	12-04-2008 07:58 AM by Hopeful	0	1,516
Neratinib (HKI-272), an irreversible pan erbB receptor tyrosine kinase inhibitor Hopeful	12-05-2008 08:03 AM by Hopeful	0	1,671
Lapatinib can activate or supress estrogen receptor (ER) signaling in cell models of Hopeful	12-05-2008 08:07 AM by Hopeful	0	1,666
Intermittent treatment of hormone-dependent breast cancer using exemestane Hopeful	12-05-2008 08:09 AM by Hopeful	0	1,540
Deletion of STAT5 prevents HER2/Neu/ErbB2-induced mammary tumor development Hopeful	12-05-2008 08:10 AM by Hopeful	0	1,577
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted Hopeful	12-05-2008 08:12 AM by Hopeful	0	1,614
electro-acupuncture for aromatase inhibitor related arthralgia in bc survivors Hopeful	12-08-2008 08:15 AM by Hopeful	0	1,548
Study on survival times for stage IV bc over 3 decades Hopeful	12-08-2008 08:16 AM by Hopeful	0	1,577
Hercetpin tx for recurrence free patients with persistent DTC in bone marrow Hopeful	12-08-2008 08:18 AM by Hopeful	0	1,634
Trastuzumab treatment in elderly patients with advanced breast cancer Hopeful	12-08-2008 08:19 AM by Hopeful	0	1,683
Trastuzumab 6 mg/kg and 4 mg/kg can be infused safely over 30 minutes Hopeful	12-08-2008 08:20 AM by Hopeful	0	1,720
HER2 positive early breast cancers: tumour demographics and trastuzumab therapy Hopeful	12-08-2008 08:21 AM by Hopeful	0	1,757
Tumor necrosis factor transactivates ErbB2 in breast cancer cells Hopeful	12-09-2008 07:54 AM by Hopeful	0	1,642
Complications of methylene blue dye infiltration for sentinel lymph node biopsy in bc Hopeful	12-10-2008 07:23 AM by Hopeful	0	1,906
Combination antiHER therapeutics efficacy of alternative dosing regimens in ER+/HER2 Hopeful	12-09-2008 07:31 AM by Hopeful	0	2,020
Evaluation of aromatase expression in mammographically dense and non-dense regions of Hopeful	12-09-2008 07:33 AM by Hopeful	0	1,871
Histologic markers of mammographic breast density: core-needle biopsy tissue from Hopeful	12-09-2008 07:34 AM by Hopeful	0	1,779
Reliable data on 5- and 10-year survival provides accurate estimates of 15-year survi Hopeful	12-09-2008 07:56 AM by Hopeful	0	1,808
RFA of lumpectomy cavities: technique to increase negative margins Hopeful	12-10-2008 07:21 AM by Hopeful	0	1,773
BCafter stopping estrogen plus progestin in postmenopausal women in the whi Hopeful	12-10-2008 07:28 AM by Hopeful	0	1,756
A novel breast tissue feature strongly associated with risk of breast cancer Hopeful	12-10-2008 07:30 AM by Hopeful	0	1,885
HER-2 expression on circulating tumor cells in metastatic breast cancer Hopeful	12-10-2008 07:31 AM by Hopeful	0	1,611
Behaviour and metastatic potential of Her2+ and Her2-(CETC) during adjuvant therapy Hopeful	12-10-2008 07:34 AM by Hopeful	0	1,527
Metastatic potential of Her2+ and Her2- CETC released during primary systemic chemo Hopeful	12-11-2008 07:36 AM by Hopeful	0	1,562
Is metabolic syndrome the link between obesity and postmenopausal breast cancer? Hopeful	12-11-2008 07:38 AM by Hopeful	0	1,671
Promoter hypermethylation is an early event in breast carcinogenesis Hopeful	12-11-2008 07:40 AM by Hopeful	0	1,609
The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathologica Hopeful	12-11-2008 07:44 AM by Hopeful	0	1,491
Remarkable complete pathologic response rate in Her2+ stage II/III pts in phase II tr Hopeful	12-11-2008 07:47 AM by Hopeful	0	1,817
HER-2/neu expression/amplification is not stable during tumor progression Hopeful	12-12-2008 07:47 AM by Hopeful	0	1,666
PR receptor levels are associated with time to AI treatment failure Hopeful	12-12-2008 07:49 AM by Hopeful	0	1,834
HER2 amplification does not alter outcome in small (1 cm) tumors Hopeful	12-12-2008 07:50 AM by Hopeful	0	1,703
Low penetrance breast cancer predisposition SNPs are site specific Hopeful	12-12-2008 07:52 AM by Hopeful	0	2,169
Pooled cardiac safety analysis of patients with HER2+ MBC receiving trastuzumab Hopeful	12-12-2008 07:54 AM by Hopeful	0	1,764
Chronobiological rhythms of cytokines level of breast cancer Hopeful	03-19-2009 07:00 AM by Hopeful	0	1,876
Presence of an in-situ component is associated with reduced biological aggressiveness Hopeful	03-18-2009 06:17 AM by Hopeful	0	1,717
The coamplification pattern of HER2/NEU amplicon and its clinical significance Hopeful	03-18-2009 06:18 AM by Hopeful	0	1,593
Tumor size vs Her2 amplification in post-meno, ER+ tamoxifen tx pts Hopeful	03-18-2009 06:22 AM by Hopeful	0	1,797
CYP2D6 pharmacogenetics stratifies tamoxifen treatment outcome Hopeful	03-18-2009 06:23 AM by Hopeful	0	1,613
The timing of recurrence after the surgery of breast cancer Hopeful	03-18-2009 06:24 AM by Hopeful	0	1,939
Is there a promotion of metastasis by autologeous breast reconstruction in patients? Hopeful	03-18-2009 06:25 AM by Hopeful	0	1,792
Soreness and sensitivity to sun exposure 10 to 16 years after breast cancer radiother Hopeful	03-19-2009 06:52 AM by Hopeful	0	1,809
Radiofrequency ablation of early breast cancer followed by delayed surgical resection Hopeful	03-19-2009 06:53 AM by Hopeful	0	1,664
Primary endocrine therapy versus chemo in postmen pts w/ ER+ bc: 5 yr results Hopeful	03-19-2009 07:02 AM by Hopeful	0	1,824
Testosterone protection: Salivary hormone levels in newly diagnosed breast cancer pts Hopeful	03-19-2009 07:04 AM by Hopeful	0	1,911
Combined ER and HER-targeted therapy in breast cancer treatment Hopeful	03-21-2009 10:23 PM by Jackie07	1	2,081
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen Hopeful	05-19-2009 06:32 AM by Hopeful	0	1,654
Treatment of node-negative infra-centimetric HER2+ invasive breast carcinomas Hopeful	05-19-2009 06:33 AM by Hopeful	0	1,557
PIK3CA gene expression signature and prognosis within the luminal-B ER+ bc Hopeful	05-19-2009 06:36 AM by Hopeful	0	1,779
Expression profile of CTC and corresponding tumors in primary breast cancer patients Hopeful	05-19-2009 06:38 AM by Hopeful	0	1,788
trastuzumab-related cardiac dysfunction in the HERA Trial with 3.6 years follow- up Hopeful	05-19-2009 06:40 AM by Hopeful	0	1,808
trial of acupuncture for the management of AI associated joint symptoms Hopeful	05-19-2009 06:41 AM by Hopeful	0	1,630
Association between HER2/neu overexpression and calcifications in breast cancer Hopeful	05-20-2009 06:23 AM by Hopeful	0	1,630
Evaluation of Adjuvant! Online to predict the effect of optimal endocrine therapy Hopeful	05-20-2009 06:26 AM by Hopeful	0	2,174
Risk factors associated with trastuzumab-associated cardiac toxicity Hopeful	05-20-2009 06:28 AM by Hopeful	0	1,779
HER-2/neu in tissue and serum at time of primary diagnosis of breast cancer Hopeful	05-20-2009 06:30 AM by Hopeful	0	1,654
Long-term follow-up and factors of survival of HER-2 positive breast cancer patients Hopeful	05-20-2009 06:31 AM by Hopeful	0	1,753
Response to neoadjuvant chemotherapy and outcome based on breast cancer subtype Hopeful	05-20-2009 08:24 AM by bejuce	1	1,994
Trastuzumab cardiotoxicity: FDA review Hopeful	05-21-2009 06:44 AM by Hopeful	0	1,770
Single Injection Depot Progesterone Prior to Surgery and Survival in BC pts Hopeful	12-17-2009 07:39 AM by Hopeful	0	757
Effects of Vaginal Estrogens on Serum Estradiol Levels in postmeno BC pts on AI/SERMs Hopeful	12-17-2009 07:51 AM by Hopeful	0	3,422
Phase II Study of a HER-2/Neu Vaccine Given Concurrently with Trastuzumab Hopeful	12-18-2009 07:38 AM by Hopeful	0	815
Genes Regulating the Progression of Human DCIS to Invasive Breast Cancer Hopeful	12-18-2009 08:13 AM by Hopeful	0	817
Fatty Acid Synthase (FASN) as a Therapeutic Target for Breast Cancer Metastasis Hopeful	12-18-2009 08:16 AM by Hopeful	0	944
Leptin-induced breast cancer cell migration requires upregulation of survivin Hopeful	04-23-2010 06:55 AM by Hopeful	0	870
Cyclin D1 regulaties progesterone receptor expression Hopeful	04-23-2010 06:58 AM by Hopeful	0	825
gene expression profiles reveals subtype-specific drug sensitivities among bc lines Hopeful	04-23-2010 07:12 AM by Hopeful	0	864
Body fat %, inflammation, and bc survival Hopeful	04-23-2010 07:14 AM by Hopeful	0	939
Intermittent treatment of ER+ BC with exemestane: Translational research Hopeful	04-23-2010 02:17 PM by Hopeful	0	1,047
MiR-21 upregulation in breast cancer cells leads to PTEN loss and Herceptin resistanc Hopeful	04-23-2010 02:29 PM by Hopeful	0	1,080
Heat shock protein 90 inhibitors: New mode of therapy to overcome AI resistance Hopeful	04-23-2010 02:33 PM by Hopeful	0	927
Molecular basis of correlation between HER2+ and sensitivity to anthracyclines Hopeful	04-23-2010 02:38 PM by Hopeful	0	938

Page 5 of 14

« First

Last »

	New posts		Hot thread with new posts
	No new posts		Hot thread with no new posts
	Thread is closed

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is On Forum Rules

All times are GMT -7. The time now is 07:03 AM.